XR Securities’s Eli Lilly LLY Stock Holding History

XR Securities’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,600	Closed	-$2.3M	–	88
2024 Q3	$2.3M	Hold	2,600	–	–	0.67%	33
2024 Q2	$2.35M	Sell	2,600 -600	-19%	-$480K	0.43%	45
2024 Q1	$2.49M	Sell	3,200 -2,200	-41%	-$1.57M	0.08%	66
2023 Q4	$3.15M	Sell	5,400 -200	-4%	-$117K	0.12%	82
2023 Q3	$3.01M	Sell	5,600 -3,400	-38%	-$1.75M	0.23%	64
2023 Q2	$4.22M	Buy	9,000 +6,400	+246%	+$2.68M	0.2%	43
2023 Q1	$893K	Sell	2,600 -1,800	-41%	-$607K	0.02%	196
2022 Q4	$1.61M	Buy	+4,400	New	+$1.56M	0.16%	119
2021 Q4	–	Sell	-10,500	Closed	-$105K	–	492
2021 Q3	$105K	Buy	10,500 +500	+5%	+$123K	0.05%	240
2021 Q2	$289K	Sell	10,000 -1,900	-16%	-$382K	0.13%	139
2021 Q1	$154K	Buy	+11,900	New	+$2.33M	0.01%	242
2020 Q1	–	Sell	-17,700	Closed	-$161K	–	258
2019 Q4	$161K	Buy	+17,700	New	+$2.05M	0.02%	138
2018 Q4	–	Sell	-13,200	Closed	-$112K	–	423
2018 Q3	$112K	Buy	+13,200	New	+$1.32M	0.03%	196

Other funds holding LLY

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

XR Securities's LLY Position: Q4 2024 in Review

XR Securities sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 285 shares — an estimated $236K sold.

XR Securities first reported a position in LLY in Q4 2018 and held it in 13 quarters. The position peaked at $2.72M in Q1 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

XR Securities reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
XR Securities sold 285 Eli Lilly shares in Q4 2024, an estimated $236K.
XR Securities first reported a position in Eli Lilly in Q4 2018 and held it in 13 quarters.
XR Securities's Eli Lilly position peaked at $2.72M in Q1 2023.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on XR Securities's 13F filing for Q4 2024, filed 17 Jan 2025.